Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097708
Status:
COMPLETED
Last Update Posted:
2014-10-03
First Post:
2004-11-29
Brief Title:
Experimental Medication For the Treatment of Generalized Anxiety Disorder
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Study Overview
Official Title:
A Double-Blind Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder
Detailed Description:
Protocol 04-001-01
The primary objective of the study is to assess under controlled conditions the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder GAD
The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication
Recruiting Participants are currently being recruited and enrolled
The primary objective of the study is to assess under controlled conditions the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder GAD
The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication
Recruiting Participants are currently being recruited and enrolled
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None